首页> 外文期刊>European Journal of Dentistry >The level of beta defensin-2 in saliva and its expression in parotid gland epithelial cells after probiotic (Lactobacillus reuteri) induction to inhibit Streptococcus mutans in caries
【24h】

The level of beta defensin-2 in saliva and its expression in parotid gland epithelial cells after probiotic (Lactobacillus reuteri) induction to inhibit Streptococcus mutans in caries

机译:益生菌(罗伊氏乳杆菌)诱导抑制龋齿中变形链球菌后唾液中β防御素2的水平及其在腮腺上皮细胞中的表达

获取原文
           

摘要

Objective: The aim of this study was to prove that administrating L. reuteri probiotics can increase the level of BD-2 saliva and BD-2 expression in the epithelial parotid glands of Wistar rats. Materials and Methods: Experimental design in this study was randomized control group post test only. Twenty-four white male Rattus norvegicus Wistar strain rats were divided into four groups. The negative control group included rats not induced by S. mutans whereas the positive control group included rats induced by S. mutans. The two treatment groups are as follows: treatment 1 (T1), the group that is induced for 14 days by L. reuteri and 7 days by S. mutans and treatment 2 (T2), the group which is induced simultaneously by S. mutans and L. reuteri for 14 days. L. reuteri culture at a concentration of 108 colony-forming unit/ml and S. mutans culture at a concentration of 1010 are induced in the oral cavity of the Wistar rats. The Elisa technique is used to examine the salivary level of BD-2, whereas the immunohistochemical technique is used to examine the BD-2 expression in the epithelial salivary glands. Results: The study shows the increasing levels of BD-2 and BD-2 expression in the epithelial parotid glands after the administration of L. reuteri probiotics. Besides, there is a relationship between the increasing expression of BD-2 in the epithelial parotid glands with the decreasing amount of S. mutans. Conclusion: Giving L. reuteri probiotic scan increases the level of saliva of BD-2 and the expression of BD-2 in the parotid glands.
机译:目的:本研究的目的是证明服用罗伊氏乳杆菌益生菌可以增加Wistar大鼠上皮腮腺的BD-2唾液水平和BD-2表达。材料和方法:本研究的实验设计仅是随机对照组,后测。将二十四只白色雄性褐家鼠Wistar菌株大鼠分为四组。阴性对照组包括变形链球菌诱导的大鼠,而阳性对照组包括变形链球菌诱导的大鼠。这两个治疗组如下:治疗1(T1),由罗伊氏乳杆菌诱导14天,变形链球菌诱导7天;治疗2(T2),由变形链球菌同时诱导。和罗伊氏乳杆菌14天。在Wistar大鼠的口腔中诱导浓度为108个菌落形成单位/ ml的罗伊氏乳杆菌培养物和浓度为1010的变形链球菌培养物。 Elisa技术用于检查唾液中BD-2的水平,而免疫组化技术用于检查BD-2在上皮唾液腺中的表达。结果:研究显示,服用罗伊氏乳杆菌益生菌后,上皮腮腺中BD-2和BD-2的表达水平增加。此外,BD-2在腮腺上皮表达的增加与变形链球菌的减少之间存在相关性。结论:对罗伊氏乳杆菌进行益生菌扫描可提高腮腺中BD-2的唾液水平和BD-2的表达。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号